Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

May 06, 2016

ENDO PHARMACEUTICALS INC. v. IMPAX LABORATORIES, INC.

Track this case

Case Number:

2:16-cv-02526

Court:

New Jersey

Nature of Suit:

Patent

Judge:

Jose L. Linares

Firms

Companies

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. July 12, 2016

    Impax Looks To Duck Endo's $100M Suit Over Drug Licensing

    Generic-drug maker Impax Laboratories asked a New Jersey federal judge Monday to toss Endo Pharmaceuticals' $100 million lawsuit alleging it is refusing to negotiate royalty payments on a generic version of the painkiller Opana ER, saying a 2010 settlement allows royalty-free marketing and sale of the drug.

1 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login